<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-vaccines-07-00072">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Spohn</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Jennings</surname>
    <given-names>G.T.</given-names>
   </name>
   <name>
    <surname>Martina</surname>
    <given-names>B.E.</given-names>
   </name>
   <name>
    <surname>Keller</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Beck</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Pumpens</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Osterhaus</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Bachmann</surname>
    <given-names>M.F.</given-names>
   </name>
  </person-group>
  <article-title>A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice</article-title>
  <source>Virol. J.</source>
  <year>2010</year>
  <volume>7</volume>
  <fpage>146</fpage>
  <pub-id pub-id-type="doi">10.1186/1743-422X-7-146</pub-id>
  <pub-id pub-id-type="pmid">20604940</pub-id>
 </element-citation>
</ref>
